CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 53 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00351299
NCT00351299Phase 2Completed
CompareCT.gov

Study of Dexmedetomidine as an Effective Sedative to Treat Acute ICU Delirium

Brigham and Women's Hospital·interventional·Posted Jul 12, 2006·Updated Jun 9, 2017

In Brief

A Phase 2 clinical trial evaluating Dexmedetomidine and Standard of Care for Delirium and Agitation. Completed, enrolled 53 participants across 1 site.

Detailed Summary

The purpose of the research is to see if dexmedetomidine (a drug that has a calming effect - a sedative) is effective for the treatment of acute delirium

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDelirium, Agitation
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 12, 2006
Enrollment StartJan 1, 2006
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 20.0 years ago

Interventions

Dexmedetomidinedrug

dexmedetomidine infusion titrated to effect

Standard of Careother

Standard of care per treating physician preference